Direktorat Registrasi ObatValid

CEFOTAXIME SODIUM

BPOM Number: GKL0319925244A1
Approved: 21 November 2024
Expiry: 30 October 2024
Form: SERBUK INJEKSI; 1050 MG

About This Registration

CEFOTAXIME SODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0319925244A1. Its current registration status is Valid, with the licence valid until 30 October 2024. The product is registered to PHAPROS TBK and manufactured by PHAPROS TBK - INDONESIA. BPOM first approved this registration in October 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 2 VIAL @ 1000 MG
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

PHAPROS TBK
Kota Jakarta Selatan, DKI Jakarta, Indonesia
NPWP: 010007938051000
owner
View profile →

Manufacturing Sites

PHAPROS TBK - INDONESIA
-, -
primary
View profile →

Ingredients (1)

CEFOTAXIME SODIUM

Market Intelligence

Owner Portfolio: PHAPROS TBK holds 210 BPOM registrations
Manufacturer Scale: PHAPROS TBK - INDONESIA produces 208 registered products
Registration Age: Registered for 6 years, 10 months
Expiry Status: Expired 696 days ago